{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:35:09Z","timestamp":1723156509458},"reference-count":17,"publisher":"Societas Neurologica Japonica","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.799","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T23:06:42Z","timestamp":1384297602000},"page":"799-802","source":"Crossref","is-referenced-by-count":1,"title":["A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity"],"prefix":"10.5692","volume":"53","author":[{"given":"Haruko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoi","family":"Kuwahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Saleun JP, Vicariot M, Deroff P, et al. Monoclonal gammopathies in the adult population of Finist\u00e8re, France. J Clin Pathol 1982;35:63-68.","DOI":"10.1136\/jcp.35.1.63"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Crawford J, Eye MK, Cohen HJ. Evaluation of monoclonal gammopathies in the \u201cwell\u201d elderly. Am J Med 1987;82:39-45.","DOI":"10.1016\/0002-9343(87)90375-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Iwanaga M, Tagawa M, Tsukasaki K, et al. Prevalence of monoclonal gammopathy of undetermined significance: study of 52,802 persons in Nagasaki City, Japan. Mayo Clin Proc 2007;82:1474-1479.","DOI":"10.1016\/S0025-6196(11)61090-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nobile-Orazio E, Barbieri S, Baldini L, et al. Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenic studies. Acta Neurol Scand 1992;85:383-390.","DOI":"10.1111\/j.1600-0404.1992.tb06033.x"},{"key":"5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial prednisolone in acute polyneuropathy. Lancet 1978;2:750-753.","DOI":"10.1016\/S0140-6736(78)92644-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sj\u00f6gren\u2019s syndrome-associated neuropathy. Brain 2005;128:2518-2534.","DOI":"10.1093\/brain\/awh605"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 2011;24:504-510.","DOI":"10.1097\/WCO.0b013e32834a87b7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Eng J Med 2002;346:564-569.","DOI":"10.1056\/NEJMoa01133202"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Rajabally YA. Neuropathy and paraproteins:review of a complex association. Eur J Neurol 2011;18:1291-1298.","DOI":"10.1111\/j.1468-1331.2011.03380.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kawagashira Y, Koike H, Tomita M, et al. Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy. J Neuropathol Exp Neurol 2010;69:1143-1157.","DOI":"10.1097\/NEN.0b013e3181fa44af"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kaku DA, England JD, Sumner AJ. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994;117:941-947.","DOI":"10.1093\/brain\/117.5.941"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nobile-Orazio E, Meucci N, Baldini L, et al. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 2000;123:710-717.","DOI":"10.1093\/brain\/123.4.710"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Dalakas MC, Quarles RH, Farrer RG, et al. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996;40:792-795.","DOI":"10.1002\/ana.410400516"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Benedetti L, Briani C, Franciotta D, et al. Long term effect of rituximab in anti-MAG polyneuropathy. Neurology 2008;71:1742-1744.","DOI":"10.1212\/01.wnl.0000335268.70325.33"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2014 first revision. J Peripher Nerv Syst 2010;3:185-195.","DOI":"10.1111\/j.1529-8027.2010.00278.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ramchandren S, Lewis RA. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 2009;22:480-485.","DOI":"10.1097\/WCO.0b013e32832fd563"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u6297SGPG IgG\u6297\u4f53\u967d\u6027\uff0c\u6297MAG\/SGPG IgM\u6297\u4f53\u9670\u6027\u306eIgM M\u86cb\u767d\u8840\u75c7\u306b\u3068\u3082\u306a\u3046\u591a\u767a\u30cb\u30e5\u30fc\u30ed\u30d1\u30c1\u30fc\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T01:50:57Z","timestamp":1498096257000},"score":1,"resource":{"primary":{"URL":"http:\/\/jlc.jst.go.jp\/DN\/JST.JSTAGE\/clinicalneurol\/53.799?lang=en&from=CrossRef&type=abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.799","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}